肠道微生物组调节脓毒症与健康状态下的体温
该研究通过电子病历数据、16S rRNA基因测序及小鼠模型,探讨肠道微生物组在脓毒症和健康状态下对体温的调节作用。在脓毒症住院患者中识别出四种预测临床结局的体温轨迹,并在116例住院患者中发现入院时肠道菌群组成可预测体温轨迹。无菌小鼠在实验性脓毒症中体温下降较常规小鼠减少,健康无菌及抗生素处理小鼠基础体温低于对照。Lachnospiraceae科在住院患者、实验性脓毒症及抗生素处理小鼠中一致与体温轨迹相关。结论认为肠道微生物组是健康和危重症体温变异的关键调节因素。
要点
- 脓毒症住院患者中存在四种体温轨迹,可预测临床结局。
- 116例住院患者入院时肠道菌群组成可预测其体温轨迹。
- 无菌小鼠在实验性脓毒症中体温下降较常规小鼠减少。
- 健康无菌及抗生素处理小鼠基础体温均低于对照动物。
- Lachnospiraceae科在住院患者、实验性脓毒症及抗生素处理小鼠中一致与体温轨迹相关。
适用人群与场景
- 脓毒症住院患者(电子病历数据及16S rRNA基因测序队列)
- 116例住院患者(用于分析肠道菌群组成与体温轨迹的关系)
- 小鼠模型:常规小鼠、无菌小鼠、抗生素处理小鼠、悉生动物
研究设计与关键结果
- 研究类型:转化分析与实验研究;样本量:患者队列116例(另用电子病历数据),小鼠实验未报告样本量;人群:脓毒症住院患者及健康小鼠;干预/方法:电子病历体温轨迹分析、16S rRNA基因测序、小鼠腹腔注射LPS建模、抗生素处理、无菌及悉生动物;主要结果:脓毒症住院患者存在四种体温轨迹并预测临床结局;116例住院患者入院时肠道菌群组成预测体温轨迹;无菌小鼠实验性脓毒症体温下降较常规小鼠减少;常规小鼠脓毒症体温反应异质性强烈由肠道菌群变异解释;健康无菌及抗生素处理小鼠基础体温低于对照;Lachnospiraceae科与体温轨迹一致相关。
证据类型、等级与局限
- 证据类型:转化分析与动物实验(含患者队列分析);局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐;结论认为肠道微生物组是健康和危重症体温变异的关键调节因素,是调节脓毒症生理异质性的主要且研究不足的靶点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Among patients with sepsis, variation in temperature trajectories predicts clinical outcomes. In healthy individuals, normal body temperature is variable and has decreased consistently since the 1860s. The biologic underpinnings of this temperature variation in disease and health are unknown. Objectives: To establish and interrogate the role of the gut microbiome in calibrating body temperature. Methods: We performed a series of translational analyses and experiments to determine whether and how variation in gut microbiota explains variation in body temperature in sepsis and in health. We studied patient temperature trajectories using electronic medical record data. We characterized gut microbiota in hospitalized patients using 16S ribosomal RNA gene sequencing. We modeled sepsis using intraperitoneal LPS in mice and modulated the microbiome using antibiotics, germ-free, and gnotobiotic animals. Measurements and Main Results: Consistent with prior work, we identified four temperature trajectories in patients hospitalized with sepsis that predicted clinical outcomes. In a separate cohort of 116 hospitalized patients, we found that the composition of patients' gut microbiota at admission predicted their temperature trajectories. Compared with conventional mice, germ-free mice had reduced temperature loss during experimental sepsis. Among conventional mice, heterogeneity of temperature response in sepsis was strongly explained by variation in gut microbiota. Healthy germ-free and antibiotic-treated mice both had lower basal body temperatures compared with control animals. The Lachnospiraceae family was consistently associated with temperature trajectories in hospitalized patients, experimental sepsis, and antibiotic-treated mice. Conclusions: The gut microbiome is a key modulator of body temperature variation in both health and critical illness and is thus a major, understudied target for modulating physiologic heterogeneity in sepsis.
参考来源
- Bongers KS, Chanderraj R, Woods RJ, et al. The Gut Microbiome Modulates Body Temperature Both in Sepsis and Health. Am J Respir Crit Care Med. 2023. PMID: 36378114. doi:10.1164/rccm.202201-0161OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。